Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -34.17% is 100% above its 5-year average of -12609.03%, near the high end of its 5-year range (-225969.57%–-7.03%).
1.43% above its 12-month average of -34.66%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -29.02%.
NET PROFIT MARGIN
-34.17%
NET PROFIT MARGIN AVG TTM
-34.66%
NET PROFIT MARGIN AVG 3Y
-4868.24%
NET PROFIT MARGIN AVG 5Y
-12609.03%
NET PROFIT MARGIN AVG 10Y
-12602.27%
NET PROFIT MARGIN AVG 15Y
-9154.79%
NET PROFIT MARGIN AVG 20Y
-5883.14%
CURRENT VS TTM AVG
+1.43%
CURRENT VS 3Y AVG
+99.30%
CURRENT VS 5Y AVG
+99.73%
CURRENT VS 10Y AVG
+99.73%
CURRENT VS 15Y AVG
+99.63%
CURRENT VS 20Y AVG
+99.42%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 564 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Geron Corporation
Market Cap
$769.83M
Net Profit Margin
-34.17%
TTM Avg
-34.66%
3Y Avg
-4868.24%
5Y Avg
-12609.03%
Market Cap
$764.21M
Net Profit Margin
-4490.89%
TTM Avg
-2245.45%
3Y Avg
-2245.45%
5Y Avg
-2245.45%
Market Cap
$762.81M
Net Profit Margin
-38.98%
TTM Avg
-18.01%
3Y Avg
-10.19%
5Y Avg
-2.91%
Market Cap
$772.90M
Net Profit Margin
-147.38%
TTM Avg
-372.93%
3Y Avg
-22199.44%
5Y Avg
-19748.48%
Market Cap
$778.72M
Net Profit Margin
1.92%
TTM Avg
0.94%
3Y Avg
-28.83%
5Y Avg
-18.64%
Market Cap
$745.42M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$798.22M
Net Profit Margin
-7.58%
TTM Avg
0.29%
3Y Avg
-4.57%
5Y Avg
-4.54%
Market Cap
$740.03M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3758.80%
5Y Avg
-9679.73%
Market Cap
$808.29M
Net Profit Margin
-14.52%
TTM Avg
7.87%
3Y Avg
-15.98%
5Y Avg
-254.57%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Geron Corporation (GERN) | $769.83M | -34.17% | -34.66% | -4868.24% | -12609.03% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $764.21M | -4490.89% | -2245.45% | -2245.45% | -2245.45% |
| Cytek Biosciences, Inc. (CTKB)vs › | $762.81M | -38.98% | -18.01% | -10.19% | -2.91% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $772.90M | -147.38% | -372.93% | -22199.44% | -19748.48% |
| Mesa Laboratories, Inc. (MLAB)vs › | $778.72M | 1.92% | 0.94% | -28.83% | -18.64% |
| Design Therapeutics, Inc. (DSGN)vs › | $745.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| AdaptHealth Corp. (AHCO)vs › | $798.22M | -7.58% | 0.29% | -4.57% | -4.54% |
| Candel Therapeutics, Inc. (CADL)vs › | $740.03M | 0.00% | 0.00% | -3758.80% | -9679.73% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $808.29M | -14.52% | 7.87% | -15.98% | -254.57% |
| InMode Ltd. (INMD)vs › | $809.04M | 20.69% | 35.62% | 36.75% | 38.26% |
Operating Margin
-29.3%
Net Profit Margin
-34.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -29.02% |
| 2026-03-31 | -7.03% |
| 2025-12-31 | -64.86% |
| 2025-09-30 | -39.02% |
| 2025-06-30 | -33.39% |
| 2025-03-31 | -50.08% |
| 2024-12-31 | -53.33% |
| 2024-09-30 | -93.55% |
| 2024-06-30 | -7639.80% |
| 2024-03-31 | -18220.39% |
| 2023-12-31 | -225969.57% |
| 2023-09-30 | -27320.12% |
| 2023-06-30 | -169748.28% |
| 2023-03-31 | -181533.33% |
| 2022-12-31 | -41393.20% |
| 2022-09-30 | -13821.89% |
| 2022-06-30 | -38516.44% |
| 2022-03-31 | -24469.92% |
| 2021-12-31 | -3078.56% |
| 2021-09-30 | -24492.66% |
| 2021-06-30 | -27639.25% |
| 2021-03-31 | -20309.49% |
| 2020-12-31 | -47574.00% |
| 2020-09-30 | -18195.37% |
| 2020-06-30 | -36800.00% |
| 2020-03-31 | -31451.92% |
| 2019-12-31 | -17000.00% |
| 2019-09-30 | -11587.79% |
| 2019-06-30 | -14098.02% |
| 2019-03-31 | -17647.37% |
| 2018-12-31 | -1946.67% |
| 2018-09-30 | -3392.12% |
| 2018-06-30 | -3333.65% |
| 2018-03-31 | -2259.75% |
| 2017-12-31 | -3889.53% |
| 2017-09-30 | -4232.52% |
| 2017-06-30 | -3681.03% |
| 2017-03-31 | -1337.62% |
| 2016-12-31 | -9023.40% |
| 2016-09-30 | -70.01% |
| 2016-06-30 | -4093.36% |
| 2016-03-31 | -1180.51% |
| 2015-12-31 | -3849.09% |
| 2015-09-30 | 76.87% |
| 2015-06-30 | -3727.49% |
| 2015-03-31 | -1734.64% |
| 2014-12-31 | -5026.40% |
| 2014-09-30 | -5968.13% |
| 2014-06-30 | -2561.29% |
| 2014-03-31 | -1780.59% |
| 2013-12-31 | -4124.89% |
| 2013-09-30 | -4560.22% |
| 2013-06-30 | -7988.39% |
| 2013-03-31 | -1555.16% |
| 2012-12-31 | -2302.32% |
| 2012-09-30 | -2508.33% |
| 2012-06-30 | -14096.92% |
| 2012-03-31 | -1494.34% |
| 2011-12-31 | -12690.84% |
| 2011-09-30 | -8873.64% |
| 2011-06-30 | -4564.50% |
| 2011-03-31 | -1620.53% |
| 2010-12-31 | -5406.38% |
| 2010-09-30 | -3359.71% |
| 2010-06-30 | -1701.40% |
| 2010-03-31 | -1812.64% |
| 2009-12-31 | -3039.83% |
| 2009-09-30 | -3081.78% |
| 2009-06-30 | -10796.72% |
| 2009-03-31 | -3786.26% |
| 2008-12-31 | -3241.18% |
| 2008-09-30 | -4673.30% |
| 2008-06-30 | -6850.51% |
| 2008-03-31 | -807.20% |
| 2007-12-31 | -235.65% |
| 2007-09-30 | -1135.75% |
| 2007-06-30 | -1573.12% |
| 2007-03-31 | 127.40% |
| 2006-12-31 | -275.19% |
| 2006-09-30 | -1360.58% |
| 2006-06-30 | -1177.74% |
| 2006-03-31 | -1545.45% |
| 2005-12-31 | 173.99% |
| 2005-09-30 | -1762.56% |
| 2005-06-30 | -65.98% |
| 2005-03-31 | -16420.34% |
| 2004-12-31 | -2803.25% |
| 2004-09-30 | -10200.00% |
| 2004-06-30 | -2443.99% |
| 2004-03-31 | -20839.92% |
| 2003-12-31 | -4874.84% |
| 2003-09-30 | -1081.99% |
| 2003-06-30 | -3258.95% |
| 2003-03-31 | -22033.33% |
| 2002-12-31 | -2467.24% |
| 2002-09-30 | -3300.92% |
